1698027-17-6 | 2-Amino-4-bromo-5-chloro-3-fluorobenzoic acid

1698027-17-6    57-13-6    1698028-10-2 

[1]CurrentPatentAssignee:ARAXESPHARMALLC-WO2018/218070,2018,A2Locationinpatent:Page/Pagecolumn173

[2]CurrentPatentAssignee:ARAXESPHARMALLC-WO2020/113071,2020,A1Locationinpatent:Page/Pagecolumn122

[3]CurrentPatentAssignee:ARVINAS;YALEUNIVERSITY-WO2019/195609,2019,A2Locationinpatent:Paragraph00492-00493

[4]CurrentPatentAssignee:CHENGDUBAIYUPHARMACEUTICALCO.,LTD.-WO2022/152313,2022,A1Locationinpatent:Page/Pagecolumn10-11

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2020/97537,2020,A2Locationinpatent:Paragraph0458

[6]CurrentPatentAssignee:YAOYATECHSHANGHAICOLTD-CN115181106,2022,ALocationinpatent:Paragraph0132-0137

[7]CurrentPatentAssignee:BIOTHERYXINC-WO2021/51034,2021,A1Locationinpatent:Paragraph0310

[8]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/164675,2016,A1Locationinpatent:Page/Pagecolumn231-233

[9]CurrentPatentAssignee:ARAXESPHARMALLC-WO2017/172979,2017,A1Locationinpatent:Paragraph0286

[10]CurrentPatentAssignee:ARAXESPHARMALLC-WO2015/54572,2015,A1Locationinpatent:Page/Pagecolumn288

[11]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/2102,2022,A1Locationinpatent:Paragraph175;177

[12]CurrentPatentAssignee:SHANGHAIPHARMACEUTICALSHOLDINGCOMPANYLIMITED-WO2022/68921,2022,A1Locationinpatent:Page/Pagecolumn195-196

CASUnavailable 

  1698027-17-6    1698028-15-7 

[1]CurrentPatentAssignee:SHANGHAIPHARMACEUTICALSHOLDINGCOMPANYLIMITED-WO2022/68921,2022,A1Locationinpatent:Page/Pagecolumn694;696

[2]CurrentPatentAssignee:ARAXESPHARMALLC-WO2015/54572,2015,A1Locationinpatent:Page/Pagecolumn289;290

[3]CurrentPatentAssignee:TAILIBIOTECHNOLOGYSHANGHAI;TYLIGANDBIOSCIENCESHANGHAI-WO2022/95960,2022,A1Locationinpatent:Page/Pagecolumn41

[4]CurrentPatentAssignee:SHANGHAIJIYUPHARMACEUTICALTECH;JIANGXIJEMINCAREGROUPCOLTD-CN113321654,2021,ALocationinpatent:Paragraph0135;0149-0153

[5]CurrentPatentAssignee:INCYTECORP-WO2021/211864,2021,A1Locationinpatent:Page/Pagecolumn147-148

[6]CurrentPatentAssignee:INCYTECORP-WO2021/211864,2021,A1Locationinpatent:Page/Pagecolumn147-148

1698027-17-6    3473-63-0    1698027-18-7 

[1]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/164675,2016,A1Locationinpatent:Page/Pagecolumn272

[2]CurrentPatentAssignee:ARVINAS;YALEUNIVERSITY-WO2019/195609,2019,A2Locationinpatent:Paragraph00552-00553

[3]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/108683,2021,A1Locationinpatent:Page/Pagecolumn179

[4]CurrentPatentAssignee:ARAXESPHARMALLC-WO2015/54572,2015,A1Locationinpatent:Page/Pagecolumn254

[5]CurrentPatentAssignee:BIOTHERYXINC-WO2021/51034,2021,A1Locationinpatent:Paragraph0196-0197

[6]CurrentPatentAssignee:LEIDOSHOLDINGS,INC.;LAWRENCELIVERMORENATIONALSECURITY,LLC;THERASINC-WO2022/177917,2022,A2Locationinpatent:Paragraph1160-1161

58534-94-4    1698027-17-6 

[1]CurrentPatentAssignee:ARAXESPHARMALLC-WO2015/54572,2015,A1

[2]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/49568,2016,A1

[3]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/164675,2016,A1

[4]CurrentPatentAssignee:ARAXESPHARMALLC-WO2017/87528,2017,A1

[5]CurrentPatentAssignee:ARAXESPHARMALLC-WO2017/58915,2017,A1

[6]CurrentPatentAssignee:ARAXESPHARMALLC-US2018/15087,2018,A1

[7]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-EP3967695,2022,A1

[8]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-WO2022/83616,2022,A1

1336963-99-5    1698027-17-6 

[1]CurrentPatentAssignee:ARAXESPHARMALLC-WO2015/54572,2015,A1

[2]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/49568,2016,A1

[3]CurrentPatentAssignee:ARAXESPHARMALLC-WO2016/164675,2016,A1

[4]CurrentPatentAssignee:ARAXESPHARMALLC-WO2017/87528,2017,A1

[5]CurrentPatentAssignee:ARAXESPHARMALLC-WO2017/58915,2017,A1

[6]CurrentPatentAssignee:ARAXESPHARMALLC-US2018/15087,2018,A1

[7]CurrentPatentAssignee:SHANGHAIJIYUPHARMACEUTICALTECH;JIANGXIJEMINCAREGROUPCOLTD-CN113321654,2021,A

[8]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-EP3967695,2022,A1

[9]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-WO2022/83616,2022,A1

[10]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-WO2021/259331,2021,A1